Trasis Is A Company Based In Lia Gebelgiumspecializing In Radiopharmacy And Nuclear Medicinefounded In 2004Trasis Is Dedicated To Advancing These Fields Through Innovative Technologies And Solutionsthe Company Has Expanded Its Operations Globally And Will Celebrate Its 20Th Anniversary In 2024 Trasis Offers A Variety Of Services To Support The Development And Production Of Radiopharmaceuticalsthese Include Regulatory Supportcleanroom Facilities For Small Batch Productionand Quality Control Solutions Like The Qc1Which Integrates Multiple Analytical Devicesthe Company Is Known For Its Innovative Productssuch As The Allinone Synthesiserminiallinoneeasyoneand Unidoseall Designed To Enhance The Synthesis And Handling Of Radiopharmaceuticalsin 2023Trasistechnologies Played A Role In The Treatment Of 3 5 Million Patients Worldwidereflecting Its Significant Impact In The Healthcare Sectorthe Company Has Also Achieved Strong Financial Growthwith Record Sales Of A 70 Million In 2023 And A 72 Million In 2024
Arab Health
United Arab Emirates
27 Jan 2025
50
Z2.A
Chemspec Europe
Germany
04 Jun 2025
STAND(S):5K14
| Company Name | Trasis Sa |
| Country |
Belgium
|
| Address | N/A |
| Telephone | N/A |
| N/A |
